Product information and disease descriptionPlace of product in therapyDisease descriptionEpidemiology
Prevalence of Niemann-Pick disease type C
9 evidence topics · 8 sources
United States diagnosed and estimated prevalence from claims data
“A total of 308 million unique individuals were represented in the database.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Of these, 294 individuals had an NPC diagnosis, yielding an identified NPC prevalence of 0.95 per million people in the United States.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“305 individuals were diagnosed with NPC and/or were treated with miglustat without having a diagnosis for either Gaucher or GM1 gangliosidosis, yielding an NPC diagnosed or treated prevalence of 0.99 per million people in the United States.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Applying this number to the distribution of NPC type (based on age of neurologic symptom onset) and corresponding mortality estimates generates an estimated 943 prevalent cases of NPC, or 2.9 cases of NPC per million people in the United States.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
United States claims analysis: data source, methods, and author affiliations
“For the first two objectives, patients were identified using the Symphony Integrated DataVerse database (Oct 2015-Jan 2020).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“For the third objective, published NPC incidence (1 per 89,000 live births) and expected mortality estimates were applied to the 2018 United States birth rate (11.6 per 1000) and population size (326.7 million).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Blair Orr, Shilpa Chatlani, Kwangchae Yoon, and Dan Gallo are shareholders and employees of Orphazyme USA Inc.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Infantile-onset share of United States prevalent cases: sponsor statement
Undiagnosed fraction in the United States: sponsor statement
Prevalence estimates in Western Europe and the United States
Oregon Medicaid drug evaluation statement of frequency
Share of adult-onset disease among prevalent cases
Diagnosed cases in Australia
“In the absence of a national register, the number of current diagnosed cases in Australia is estimated by clinical services as between 25 and 33, although this is widely considered an underestimate, with many cases likely undetermined or in some cases misdiagnosed.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote